Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-03

Clinical Trial Update: Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nicotinamide in patients with chronic lymphocytic leukemia who have a history of non-melanoma skin cancer is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide (nicotinamide)

Snippet

Sponsor: University of Utah | Conditions: Chronic Lymphocytic Leukemia, Non-melanoma Skin Cancer (NMSC) | Phase 2 | Status: RECRUITING